These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 22354280)

  • 1. Zolpidem oral spray (zolpimist) for insomnia.
    Med Lett Drugs Ther; 2012 Feb; 54(1384):14-5. PubMed ID: 22354280
    [No Abstract]   [Full Text] [Related]  

  • 2. Zolpidem for insomnia.
    Med Lett Drugs Ther; 1993 Apr; 35(895):35-6. PubMed ID: 8386301
    [No Abstract]   [Full Text] [Related]  

  • 3. Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study.
    Staner L; Eriksson M; Cornette F; Santoro F; Muscat N; Luthinger R; Roth T
    Sleep Med; 2009 Jun; 10(6):616-20. PubMed ID: 18996742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insomnia: zolpidem extended-release for the treatment of sleep induction and sleep maintenance symptoms.
    Doghramji PP
    MedGenMed; 2007 Jan; 9(1):11. PubMed ID: 17435620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding GABA and its relation to insomnia and therapeutics.
    Walsh JK
    J Clin Sleep Med; 2006 Apr; 2(2):S5-6. PubMed ID: 17557500
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose sublingual zolpidem (Intermezzo) for insomnia due to middle-of-the-night awakening.
    Med Lett Drugs Ther; 2012 Apr; 54(1387):25-6. PubMed ID: 22469649
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T; Soubrane C; Titeux L; Walsh JK;
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zolpidem extended release in insomnia: profile report.
    Moen MD; Plosker GL
    Drugs Aging; 2006; 23(10):843-6. PubMed ID: 17067187
    [No Abstract]   [Full Text] [Related]  

  • 10. Eight weeks of non-nightly use of zolpidem for primary insomnia.
    Walsh JK; Roth T; Randazzo A; Erman M; Jamieson A; Scharf M; Schweitzer PK; Ware JC
    Sleep; 2000 Dec; 23(8):1087-96. PubMed ID: 11145323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
    Hajak G; Hedner J; Eglin M; Loft H; Stórustovu SI; Lütolf S; Lundahl J;
    Sleep Med; 2009 Aug; 10(7):705-12. PubMed ID: 19346160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypnotic dependence: zolpidem and zopiclone too.
    Prescrire Int; 2001 Feb; 10(51):15. PubMed ID: 11503851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
    Walsh JK; Soubrane C; Roth T
    Am J Geriatr Psychiatry; 2008 Jan; 16(1):44-57. PubMed ID: 18165461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia.
    Hoehns JD; Perry PJ
    Clin Pharm; 1993 Nov; 12(11):814-28. PubMed ID: 8275648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study.
    Voshaar RC; van Balkom AJ; Zitman FG
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):301-6. PubMed ID: 15163440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States.
    Jhaveri M; Seal B; Pollack M; Wertz D
    Curr Med Res Opin; 2007 Jun; 23(6):1431-43. PubMed ID: 17559740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms.
    Barkin RL
    Am J Ther; 2007; 14(3):299-305. PubMed ID: 17515707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysomnographic study of intermittent zolpidem treatment in primary sleep maintenance insomnia.
    Parrino L; Smerieri A; Giglia F; Milioli G; De Paolis F; Terzano MG
    Clin Neuropharmacol; 2008; 31(1):40-50. PubMed ID: 18303490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM; Lee KA; Scharf MB
    Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.